Table 4.
Distribution of anti-phosphatase and tensin homolog and p27 expressions in the endometrial hyperplasia and endometrial carcinoma cases
| Category | Subcategory | EH | EC | P |
|---|---|---|---|---|
| Positive PTEN/p27, EH=2, EC=14 | PTEN+/p27+ | 1 | 6 | 1. Chi-square test for comparison of the 4 categories, P=0.06122 2. Using the independent t-test for the subcategory, P=0.0808 |
| PTEN++/p27+ | 1 | 2 | ||
| PTEN+++/p27+ | 0 | 1 | ||
| PTEN+/p27++ | 0 | 1 | ||
| PTEN+/p27+++ | 0 | 1 | ||
| PTEN++/p27++ | 0 | 2 | ||
| PTEN++/p27+++ | 0 | 1 | ||
| Positive PTEN and negative p27, EH=5, EC=7 | PTEN+/p27− | 3 | 1 | |
| PTEN++/p27− | 1 | 2 | ||
| PTEN+++/p27− | 1 | 4 | ||
| Negative PTEN and positive p27, EH=1, EC=11 | PTEN−/p27+ | 1 | 7 | |
| PTEN−/p27++ | 0 | 3 | ||
| PTEN−/p27+++ | 0 | 1 | ||
| Negative PTEN and p27 | PTEN−/p27− | 12 | 18 | |
| Total | 20 | 50 | ||
P value is significant at P≤0.05. PTEN: Phosphatase and tensin homolog, EH: Endometrial hyperplasia, EC: Endometrial carcinoma